Licart System
Product Images NDC 71858-0305

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Licart (NDC 71858-0305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Licart 01)

FDA Label Image

Figure 1 (Licart 02)

FDA Label Image

Figure 2 (Licart 03)

FDA Label Image

Principal Display Panel (15 Patch Carton)

Principal Display Panel (15 Patch Carton)
Licart is a prescription topical system containing diclofenac epolamine. Each system should be changed once daily for pain relief. It is important to store the product at the recommended temperatures, keep it out of reach of children and pets, and avoid contact with the eyes. Each Licart contains 182mg of diclofenac epolamine and a host of inactive ingredients. The medication also has dosage instructions and information on how to use it. The topical systems should be applied on dry skin by removing the clear liner and firmly pressing the LICART in place. Used topical systems should be folded and thrown away where children or pets cannot reach them. Unused topical systems should be discarded six months after opening envelope.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.